Scientific Program

2017 On-Site Program Book
 
Abstract Book

Thursday, September 21, 2017

15:00 – 19:00 Registration
Location: Sala Londra Foyer
12:00 – 18:30 Committee Meetings
Location: Room Praga

  • 12:00- 13:00: Mediastinal Working Group
  • 13:00- 14:00: Education Committee
  • 14:00- 15:00: Biology and Tissue Bank
  • 15:00- 16:00: Research & Infrastructure (including clinical trials)
  • 16:00- 16:30: Outlier WG
  • 16:30- 17:00: Steering Committee
  • 17:00- 18:00: Database Committee
  • 18:00- 18:30: Regional Champions
18:30 Welcome Reception
Location: Exhibit Hall

Friday, September 22, 2017

08:00 – 17:00 Registration
Location: Sala Londra Foyer
08:10 – 08:25 ITMIG Business Meeting
Location: Room Londra
08:25 – 08:30 Opening remarks, introduction of industry attendees
Location: Room Londra
08:30 – 10:00 Invited Speaker Session 1: The History of Thymic Surgery
Location: Room Londra
Chair: TBA

  • 08:30 – 08:40 The History of Thymic Surgery for MG – Guiliano Maggi, Italy
  • 08:40 – 09:00 The Evolution of Thymic Malignancies Management in Japan – Meinoshin Okumura, Japan
  • 09:00 – 09:20 The Evolution of Thymic Tumors Pathological Classification – Mirella Marino, Italy
  • 09:20 – 09:40 The Evolution of Thymic Surgery Through the Years – Joshua Sonett, USA
  • 09:40 – 09:55 From the Old to the New: The EURACAN Project – Nicolas Girard, France
10:00-10:30 Networking Break, Poster Viewing and Exhibit Tour
Location: Sala Londra Foyer
10:30-12:00 Abstract Session 1: Clinical Science
Location: Room Londra
Chair: TBA

  • 10:30 – 10:45 Post Op Radiation May Be Detrimental in Thymoma but Not in Thymic Carcinoma Tumors (TET) – Feng-Ming Kong, USA
  • 10:45 – 11:00 A Phase II Study of Chemotherapy Concurrent with Radiotherapy in Patients with Unresectable Advanced Thymic Tumors – Kai-Liang Wu, China
  • 11:00 – 11:15 New Proposed Treatment for Pure Red Cell Aplasia Thymoma-Related – Giovannella Palmieri, Italy
  • 11:15 – 11:30 Prevalence of Autoimmune Disease in Thymic Epithelial Tumors (TET) Insights from RYTHMIC – Marie-Eve Boucher, France
  • 11:30 – 11:45 Early Prediction of Response to Target Therapy by FDG-PET in ThymicEpithelial Tumors: A Monocentric Experience – Margaret Ottaviano, Italy
  • 11:45 – 12:00 Factors Associated with Survival in Patients with Thymoma: Study of 523 Cases from One Institution – Feng-Ming Kong, USA
12:00-13:30 Lunch
12:00-12:30 Committee Meeting

  • Thymic Carcinoma WG
12:30-13:30 Industry Lunch Session Supported by: Intuitive
Location: Room LondraSession Title: Robotic-assisted Surgery in Thymic Pathologies
Session Description: The Experience from Established Centers in Europe: Outcomes and Perspectives
13:30-15:00 Invited Speaker Session 2: Thymic Carcinoid Tumors
Location: Room Londra
Chair: Pier Luigi Filosso, Italy

  • 13:30 – 13:45 Pathological Overview of Thymic NETs – Mauro Papotti, Italy
  • 13:45 – 14:05 The Surgical Treatment of Thymic NETs – Vincent Fang, China
  • 14:05 – 14:25 New Options for Thymic NETs Medical Treatment – Giovannella Palmieri, Italy
  • 14:25 – 14:45 The Role of Radiotherapy in Thymic NETs – Umberto Ricardi, Italy
  • Discussion & Questions
15:00 – 15:30 Networking Break, Poster Viewing and Exhibit Tour
Location: Sala Londra Foyer
15:30 – 16:30 Abstract Session 2: Basic Science
Location: Room Londra
Chair: TBA

  • 15:30 – 15:45 The Integrated Genomic Landscape of Thymic Epithelial Tumors: A Report by the TCGA Research Network – Milan Radovich, USA
  • 15:45 – 16:00 Identification of Differentially Expressed Genes between Thymoma and Paraneoplastic Thymic Tissues – Lei Yu, China
  • 16:00 – 16:15 The Imbalance of Th17/Treg and ROR?T /FoxP3 in Thymoma with MG – Peng Zhang, China
  • 16:15 – 16:30 Characterization of Autoantibody in Thymoma with Myasthenia Gravis by Single-Cell Sequencing of B-cells Sukhmani Padda, USA
16:30 – 16:45 Break
16:45-17:45 Invited Speaker Session 3: Radiation Therapy
Location: Room Londra
Chair: Andreas Rimner, USA

  • 16:45 – 16:55 Challenging Clinical Scenarios for Radiation Treatment Planning – Andreas Rimner, USA
  • 16:55 – 17:10 Postsurgical Radiological Findings – Andrea Ferraris, Italy
  • 17:10 – 17:25 Pathological Features with Therapeutic Implications – Alexander Marx, Germany
  • 17:25 – 17:35 Proton Therapy for Thymic Malignancies – Charles Simone II, USA
  • Discussion & Questions
19:00 ITMIG Networking Dinner

Saturday, September 23, 2017

8:00-9:00 Abstract Session 3: Translational Science
Location: Room Londra
Chair: TBA

  • 8:00 – 8:15 Expression of L-Type Amino Acid Transporter 1 Is Possible Diagnostic and Prognostic Marker of Thymic Carcinoma – Sumiko Maeda, Japan
  • 8:15 – 8:30 Increased CFLIP Expression in Thymic Epithelial Tumors Blocks Autophagy via NF-?B Signalling – Djeda Belharazem, Germany
  • 8:30 – 8:45 Quantitative Proteomic Analysis of Type B Thymoma using Data Independent Acquisition Mass Spectrometry – Qiangling Sun, China
  • 8:45 – 9:00 Thymic Epithelial Tumors Phenotype Relies on miR-145-5p Epigenetic Regulation – Mirella Marino, Italy
9:00-10:00 Abstract Session 4: Surgery
Location: Room Londra
Chair: TBA

  • 9:00 – 9:15 Robotic Thymectomy in Thymic Epithelial Tumors: A Propensity Score Matching Study of 112 Consecutive Cases. – Samina Park, South Korea
  • 9:15 – 9:30 Comparision of Left and Right-Sided Approach Video-Assisted Thymectomy for Centrally Located Thymic Tumors – Chenxi Zhong, China
  • 9:30 – 9:45 Impact of Lymph Node Dissection for Thymic Malignancies: Multi-Institutional Propensity Score Matched Analysis – Yoohwa Hwang, South Korea
  • 9:45 – 10:00 IS Video-Assisted Thymectomy Appropriate for Large Thymomas? Results of a Propensity Score Matching Analysis – Wenhan Weng, China
10:00-10:45 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall
10:45-12:10 Invited Speaker Session 4: Stage 4: Novel Approaches, Immunotherapy and Targeted Therapy for TET
Location: Room Londra
Chair: Giorgio Scagliotti, Italy

  • 10:45 – 11:10 Use of Immune Checkpoint Inhibitors in TET: Where are we now and where are we heading – TBA
  • 11:10 – 11:35 Use of Targeted Therapy in TET Including Incorporation of TCGA and Molecular Data on TET to Inform Next Trials – Nicolas Girard, France
  • 11:35 – 11:50 Let us Not Forgot About Traditional Chemotherapy (overview of available options) – TBA
  • 11:50 – 12:10 Panel Discussion – How do we Choose our Therapies and Future Trial Designs in TET? – Giorgio Scagliotti, Italy; Giuseppe (Beppe) Giaccone, USA; Nicolas Girard France; Patrick Loehrer, USA; Heather Wakelee, USA; Giovannella Palmieri, Italy; Sukhmani Padda, USA
12:00-12:30 Committee Meeting

  • Membership Committee
12:30-13:30 Committee Meeting

  • Pathology
12:10 – 13:30 Lunch
13:30 – 15:30 Tumor Board
Location: Room Londra
15:30 – 16:00 Networking Break, Poster Viewing and Exhibit Tour
Location: Exhibit Hall
16:00-17:00 Invited Speaker Session 5: Innovative Approaches for Stage III Thymic Tumors
Location: Room Londra
Chair: TBA

  • 16:00 – 16:10 Extended Surgical Resection for Stage III Thymic Tumors – Ugo Pastorino, Italy
  • 16:10 – 16:20 Induction Chemotherapy for Locally Advanced Thymic Tumors – Sukhmani Padda, USA
  • 16:20 – 16:30 Induction Chemoradiation for Unresectable Thymic Tumors – Michael Lanuti, USA
  • 16:30 – 16:40 Potential Novel Approaches for Locally Advanced Thymic Tumors – TBA
  • 16:40 – 16:50 Postoperative Adjuvant Chemotherapies for Completely Resected Stage III Thymic Carcinoma – Giulia Pasello, Italy
  • 16:50 – 17:00 Discussions & Questions
17:00-17:30 Concluding Comments
Location: Room Londra
19:00 Dinner at own espense
Location: TBD
Switch To Full Site